JPH04305509A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPH04305509A JPH04305509A JP14229491A JP14229491A JPH04305509A JP H04305509 A JPH04305509 A JP H04305509A JP 14229491 A JP14229491 A JP 14229491A JP 14229491 A JP14229491 A JP 14229491A JP H04305509 A JPH04305509 A JP H04305509A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- external preparation
- urea
- acid
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000004202 carbamide Substances 0.000 claims abstract description 21
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 16
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 3
- -1 vitamin A acid ester Chemical class 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 17
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 229910052708 sodium Inorganic materials 0.000 abstract description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- 229930003316 Vitamin D Natural products 0.000 abstract description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 229910052700 potassium Inorganic materials 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- 235000019166 vitamin D Nutrition 0.000 abstract description 2
- 239000011710 vitamin D Substances 0.000 abstract description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 229930002330 retinoic acid Natural products 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 238000007796 conventional method Methods 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 9
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 238000005342 ion exchange Methods 0.000 description 9
- 229940055577 oleyl alcohol Drugs 0.000 description 9
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 7
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 7
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 7
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 229940082500 cetostearyl alcohol Drugs 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 235000011118 potassium hydroxide Nutrition 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 6
- 229940099259 vaseline Drugs 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 3
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 230000037393 skin firmness Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 150000004370 vitamin A ester derivatives Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000004508 retinoic acid derivatives Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、新規な皮膚外用剤に関
し、さらに詳しくは、皮膚の新陳代謝を活発にし、皮膚
の弾力性を増し、皮膚の保護と水分の保持性に優れた効
果を有し、うるおいを与え、さらに肌荒れ改善効果にも
優れた皮膚外用剤に関する。[Industrial Application Field] The present invention relates to a novel skin preparation for external use, and more specifically, it has the effect of activating skin metabolism, increasing skin elasticity, and having excellent effects on skin protection and moisture retention. The present invention relates to a skin preparation for external use that provides moisture and has an excellent effect on improving rough skin.
【0002】0002
【従来の技術】尿素は生体内に存在し、蛋白のポリベソ
チドに変化を与える結果、その可能性を増大させ、抗菌
作用、蛋白溶解変質作用、水和減少、すなわち水分保持
能力の亢進作用等皮膚化学的に重要な薬理作用があり、
角化症の治療薬として用いられており、またこれを化粧
料中に配合した場合、皮膚に適するアミノ酸を保持させ
るための保護剤としての効果や、その湿潤効果、細胞賦
活効果、創傷治癒効果等が期待される。[Prior Art] Urea exists in living organisms, and as a result of changing the polybesotide of proteins, it increases the possibility of antibacterial effects, proteolytic alteration effects, decreases hydration, that is, enhances water retention ability, etc. on the skin. It has chemically important pharmacological effects,
It is used as a treatment for keratosis, and when incorporated into cosmetics, it has the effect of protecting the skin by retaining amino acids suitable for the skin, its moisturizing effect, cell activation effect, and wound healing effect. etc. are expected.
【0003】0003
【発明が解決しようとする課題】従来の技術しかしなが
ら、尿素の皮膚外用剤への単独の配合では、その期待さ
れる作用効果がいまだ充分ではなく、またそのため配合
量を増加すれば皮膚外用剤の安定性に悪影響をおよぼす
こと、ベタツキが生ずること等の欠点を有していた。[Problems to be Solved by the Invention] Prior Art However, when urea is added alone to external skin preparations, its expected effects are still not sufficient, and therefore, increasing the amount of urea added to external skin preparations results in It has disadvantages such as having an adverse effect on stability and causing stickiness.
【0004】発明の目的
本発明者らは上記の事情に鑑み、鋭意研究した結果、尿
素に、トラネキサム酸、もしくはその塩類、もしくはそ
の誘導対とを配合した皮膚外用剤は、水分の保持性が相
乗的に増大し、皮膚を滑らかとなし、適度の「潤い」と
「はり」を与え、さらには肌荒れ改善効果を有すること
を見出し、これら知見に基いて本発明を完成するに至っ
た。Purpose of the Invention In view of the above circumstances, the present inventors conducted extensive research and found that an external preparation for skin containing urea and tranexamic acid, its salts, or derivatives thereof has a high water retention property. It has been found that the skin increases synergistically, makes the skin smooth, provides appropriate "moisturization" and "firmness," and also has the effect of improving rough skin.Based on these findings, the present invention was completed.
【0005】[0005]
【課題を解決するための手段】すなわち本発明は尿素と
、トラネキサム酸、もしくはその塩類、もしくはその誘
導体、またはこれらの混合物とを配合することを特徴と
する皮膚外用剤である。[Means for Solving the Problems] That is, the present invention is an external preparation for skin, which is characterized in that it contains urea and tranexamic acid, a salt thereof, a derivative thereof, or a mixture thereof.
【0006】以下、本発明の構成について詳述する。本
発明に用いられる尿素としては通常市販されているもの
で構わない。The configuration of the present invention will be explained in detail below. As the urea used in the present invention, any commercially available urea may be used.
【0007】配合量は、一般的には皮膚外用剤全量中の
0.1〜30重量%、好ましくは、1〜10重量%であ
る。0.1重量%未満では、本発明の効果が十分に発揮
されず、30重量%を越えて配合すると尿素の結晶析出
が起こりやすく、また効果の増加は実質上望めない。[0007] The blending amount is generally 0.1 to 30% by weight, preferably 1 to 10% by weight based on the total amount of the skin external preparation. If the amount is less than 0.1% by weight, the effect of the present invention will not be fully exhibited, and if it exceeds 30% by weight, crystal precipitation of urea will likely occur, and no substantial increase in the effect can be expected.
【0008】本発明に用いられるトラネキサム酸、もし
くはその塩類もしくはその誘導体は抗プラスミン剤とし
一般に用いらてており、化粧品用途では、安全性が高い
事を特徴とする成分として知られている。(特願昭42
−36980)またその製造法は特許第240611号
、特許第242664号、特許第480411号、特許
第488168号によって知られている。[0008] Tranexamic acid, its salts, or its derivatives used in the present invention are generally used as anti-plasmin agents, and are known as components characterized by high safety in cosmetic applications. (Special request 1977
-36980) The manufacturing method thereof is also known from Japanese Patent No. 240611, Japanese Patent No. 242664, Japanese Patent No. 480411, and Japanese Patent No. 488168.
【0009】トラネキサム酸は融点262〜267℃、
白色の結晶または粉末で臭いはなく、味は苦い。トラネ
キサム酸の塩は通常使用される塩として、Na、Mg、
Ca、K等の金属塩類、硫酸塩等があり、誘導体として
はビタミンA酸エステル、ビタミンAエステル、ビタミ
ンEエステル、ビタミンCエステル、ビタミンDエステ
ル等のビタミンエステル類、フェニルエステル類、N,
N−マレオイルミノトラネキサム酸等が挙げられるが、
これらに限定されるものではない。Tranexamic acid has a melting point of 262-267°C,
It is a white crystal or powder with no odor and a bitter taste. Commonly used salts of tranexamic acid include Na, Mg,
There are metal salts such as Ca and K, sulfates, etc., and derivatives include vitamin A acid esters, vitamin A esters, vitamin E esters, vitamin C esters, vitamin D esters and other vitamin esters, phenyl esters, N,
Examples include N-maleoylminotranexamic acid,
It is not limited to these.
【0010】本発明においては上記トラネキサム酸、も
しくはその塩類、もしくはその誘導体の中から一種また
は二種以上が任意に選ばれて用いられ、そほ配合量は、
皮膚外用剤全量中の0.1〜30重量%であり、好まし
くは6〜20重量%である。0.1重量%未満では、本
発明の効果が十分に発揮されず、30重量%を越えて配
合しても効果の増加は実質上望めない。[0010] In the present invention, one or more of the above tranexamic acid, its salts, or its derivatives are arbitrarily selected and used, and the blending amount is as follows:
The amount is 0.1 to 30% by weight, preferably 6 to 20% by weight, based on the total amount of the skin external preparation. If the amount is less than 0.1% by weight, the effect of the present invention will not be fully exhibited, and even if it is added in excess of 30% by weight, no substantial increase in the effect can be expected.
【0011】本発明の皮膚外用剤には上記必須構成成分
に加えて、必要に応じて、通常医薬品、化粧品分野で用
いられるその他の成分、例えばエデト酸、二、三または
四ナトリウム、クエン酸ナリトリウム、メタリン酸ナリ
トリウム、メタリン酸ナトナトリウム酸の金属イオン封
鎖剤、ブチルヒドロキシトルエン(BHT)、没食子酸
プロピル、dl−α−トコフェロール等の酸か防止剤、
界面活性剤、紫外線吸収剤、香料、水、エタノール、イ
ソプロパノール等のアルコール類、増粘剤、色剤、粉末
、薬剤、クエン酸、リンゴ酸等の有機酸、リン酸等の無
機酸等を本発明の効果を損なわない範囲内で用いること
ができる。In addition to the above-mentioned essential components, the external skin preparation of the present invention may optionally contain other ingredients commonly used in the pharmaceutical and cosmetic fields, such as edetic acid, di-, tri-, or tetrasodium, and sodium citrate. , sodium metaphosphate, sequestering agents such as sodium metaphosphate, acid inhibitors such as butylated hydroxytoluene (BHT), propyl gallate, dl-α-tocopherol,
Surfactants, ultraviolet absorbers, fragrances, water, alcohols such as ethanol and isopropanol, thickeners, coloring agents, powders, drugs, organic acids such as citric acid and malic acid, and inorganic acids such as phosphoric acid, etc. It can be used within a range that does not impair the effects of the invention.
【0012】本発明の皮膚外用剤の剤型は任意であり、
溶液型、可容化系、乳化系、粉末分散系、水−油二層系
水―油−粉末三層系等、どのような剤型でもかまわ
ない。[0012] The dosage form of the skin external preparation of the present invention is arbitrary;
Any dosage form may be used, such as solution type, solubilized type, emulsion type, powder dispersion type, water-oil two-layer type, water-oil-three-layer type, etc.
【0013】また、本発明の皮膚外用剤の用途も任意で
あり、化粧水、乳液、クリーム、パック等のフェーシャ
ル用またはボディー用皮膚外用剤やヘアトニック、ヘヤ
クリーム、シャンプー、ヘアリンス等の頭髪用皮膚外用
剤に用いることができる。[0013] Furthermore, the use of the external skin preparation of the present invention is arbitrary, and it can be used for facial or body skin preparations such as lotions, emulsions, creams, and packs, and for hair such as hair tonics, hair creams, shampoos, and hair rinses. It can be used in external preparations for the skin.
【0014】[0014]
【発明の効果】本発明の皮膚外用剤は、尿素にトラネキ
サム酸、その塩、その誘導体を配合するので、皮膚の新
陳代謝を活発にし、皮膚の粘弾力を増し、皮膚の保護と
水分の保持性に優れ、適度なうるおい、肌のハリを与え
更に、肌荒れ改善効果にも優れた皮膚外用剤である。[Effects of the Invention] The skin external preparation of the present invention contains tranexamic acid, its salt, and its derivatives in urea, so it activates skin metabolism, increases the skin's viscosity and elasticity, and has skin protection and moisture retention properties. It is an external preparation for the skin that provides moderate moisture and firmness to the skin, and is also excellent in improving rough skin.
【0015】[0015]
【実施例】次に実施例をあげて、本発明を具体的に説明
する。本発明はこれにより限定されるものではない。配
合量は重量%である。[Examples] Next, the present invention will be specifically explained with reference to Examples. The present invention is not limited thereby. The blending amount is in weight%.
【0016】[0016]
【実使用試験】80名の女性を各4群に分けパネルとし
た。サンプルとして下記の実施例1〜3及び比較例1〜
3を用いた。[Practical test] 80 women were divided into four groups each to form a panel. The following Examples 1 to 3 and Comparative Examples 1 to 3 are used as samples.
3 was used.
【0017】第1群には実施例1及び比較例1の化粧水
を、第2群には実施例2及び比較例2のクリームを、第
3群には実施例3及び比較例3の化粧水を使用テストさ
せた。The first group received the lotions of Example 1 and Comparative Example 1, the second group received the creams of Example 2 and Comparative Example 2, and the third group received the lotions of Example 3 and Comparative Example 3. Tested using water.
【0018】毎日朝と夜の2回、洗顔後実施例の化粧料
を適量顔面左側に、比較例の化粧料を顔面右側に、2週
間にわたって、塗布することにより行った。評価は、下
記の4項目につきその有効性を判定した。結果を表1〜
表6に示す。Twice a day, in the morning and at night, after washing the face, an appropriate amount of the cosmetic of the example was applied to the left side of the face, and the cosmetic of the comparative example was applied to the right side of the face for two weeks. The evaluation determined the effectiveness of the following four items. The results are shown in Table 1~
It is shown in Table 6.
【0019】
実施例1 化粧水
重量% エタノール
8.0 2−ピロリドン−5
−
2.0
カルボン酸ナトリウム ポリオキシエチレン
(20モル)
1.8 オ
レイルアルコールエーテル トラネキサム酸
0.1 尿素
0.5 プルラン
0.05 ホホバ油
0.5
苛性カリ
0.015 EDTA−3Na
0.01 香 料
0.
1 イオン交換水
残量 製 法
常法により化粧水を製造した。Example 1 Lotion
Weight% ethanol
8.0 2-pyrrolidone-5
−
2.0
Sodium carboxylate polyoxyethylene (20 mol)
1.8 Oleyl alcohol ether tranexamic acid
0.1 Urea
0.5 Pullulan
0.05 Jojoba oil
0.5
caustic potash
0.015 EDTA-3Na
0.01 fragrance
0.
1 Ion exchange water
Remaining amount Manufacturing method A lotion was manufactured using a conventional method.
【0020】
比較例1 化料水
重量% エタノール
8.0 2−ピロリドン−5
−
2.0
カルボン酸ナトリウム ポリオキシエチレン
(20モル)
1.8 オレイ
ルアルコールエーテル 尿素
0.5 プル
ラン
0.05 ホホバ油
0.5 苛性カリ
0.01
5 EDTA−3Na
0.01 香 料
0.1 イオン交換
水
残量
製 法
常法により化粧水を製造した。Comparative Example 1 Chemical water
Weight% ethanol
8.0 2-pyrrolidone-5
−
2.0
Sodium carboxylate polyoxyethylene (20 mol)
1.8 Oleyl alcohol ether urea
0.5 Pullulan
0.05 Jojoba oil
0.5 caustic potash
0.01
5 EDTA-3Na
0.01 fragrance
0.1 Ion exchange water
Remaining amount
Manufacturing method A lotion was manufactured using a conventional method.
【0021】
実施例2 クリーム
重量% 1,3−ブチレングリコール
5.0 ポリエチレングリコール4000
1.0 グリセリン
2.0 スクワラン
20.0 ワセリン
5
.0 セトステアリルアルコール
3.0 ポリオキシエチレン(20モル)
1.
5 オレイルアルコールエーテル グ
リセリルモノステアレート
1.5 ト
ラネキサム酸のNa塩
0.1
尿素
0.5 乳酸ソーダ
2.0 キサンタン
ガム(ケルトロール商品名)
0.05 メチルパラベン
0.1 エチル
パラベン
0.
2 EDTA−3Na
0.01 香 料
0.2 イオン交換
水
残量
製 法
常法によりクリームを製造した。Example 2 Cream
Weight% 1,3-butylene glycol
5.0 Polyethylene glycol 4000
1.0 Glycerin
2.0 Squalane
20.0 Vaseline
5
.. 0 Cetostearyl alcohol
3.0 Polyoxyethylene (20 mol)
1.
5 Oleyl alcohol ether glyceryl monostearate
1.5 Sodium salt of tranexamic acid
0.1
urea
0.5 Sodium lactate
2.0 Xanthan gum (Keltrol brand name)
0.05 Methylparaben
0.1 Ethylparaben
0.
2 EDTA-3Na
0.01 fragrance
0.2 Ion exchange water
Remaining amount
Manufacturing method A cream was manufactured using a conventional method.
【0022】
比較例2 クリーム
重量% 1,3−ブチレングリコール
5.0 ポリアエチレングリコール4000
1
.0 グリセリン
2.0 スクワラン
20.0 セトステアリ
ルアルコール
3.0 ポリオキシ
エチレン(20モル)
1.5 オ
レイルアルコールエーテル グリセリルモノステアレ
ート
1.5 尿素
0.5
乳酸ソーダ
2.0 キサンタンガム(ケルトロール商品名
) 0.
05 メチルパラベン
0.1 エチルパラベン
0.2 EDTA−3Na
0.01 香
料
0.2 イオン交換水
残量 製 法
常法によりクリームを製造した。Comparative Example 2 Cream
Weight% 1,3-butylene glycol
5.0 Polyethylene glycol 4000
1
.. 0 glycerin
2.0 Squalane
20.0 Cetostearyl alcohol
3.0 Polyoxyethylene (20 mol)
1.5 Oleyl alcohol ether glyceryl monostearate
1.5 Urea
0.5
lactic acid soda
2.0 Xanthan gum (Keltrol brand name) 0.
05 Methylparaben
0.1 Ethylparaben
0.2 EDTA-3Na
0.01 incense
fee
0.2 Ion exchange water
Remaining amount Production method A cream was produced using a conventional method.
【0023】
実施例3 乳 液
重量% グリセリン
2.0 スクワラン
5.0
ワセリン
1.0 セトステアリルアルコール
0.3 ポリオキシエチレン(20モル)
1.5 オレイルアルコールエー
テル グリセリールモノオレート
1.5 トラネキサム酸のカリウム塩
0.1 ポリアクリル酸ナ卜リウム
0.03 エチルパラベン
0.2 尿素
0.5 苛
性カリ
0.1 EDTA−3Na
0.03 香 料
0.2
イオン交換水
残量 製 法
常法により乳液を得た。Example 3 Emulsion
Weight% glycerin
2.0 Squalane
5.0
Vaseline
1.0 Cetostearyl alcohol
0.3 Polyoxyethylene (20 mol)
1.5 Oleyl alcohol ether glyceryl monooleate
1.5 Potassium salt of tranexamic acid
0.1 Sodium polyacrylate
0.03 Ethylparaben
0.2 Urea
0.5 caustic potash
0.1 EDTA-3Na
0.03 fragrance
0.2
ion exchange water
Remaining amount Production method An emulsion was obtained by a conventional method.
【0024】
比較例3 乳 液
重量% グリセリン
2.0 スクワラン
5.0
ワセリン
1.0 セトステアリルアルコール
0.3 ポリオキシエチレン(20モル)
1.5 オレイルアルコールエー
テル グリセリルモノオレート
1.5 ポリアクリル酸ナトリウム
0.03 エチルパラベン
0.2 尿素
0.5
苛性カリ
0.1 EDTA−3Na
0.03 香 料
0.2
イオン交換水
残量 製 法
常法により乳液を得た。Comparative Example 3 Emulsion
Weight% glycerin
2.0 Squalane
5.0
Vaseline
1.0 Cetostearyl alcohol
0.3 Polyoxyethylene (20 mol)
1.5 Oleyl alcohol ether glyceryl monooleate
1.5 Sodium polyacrylate
0.03 Ethylparaben
0.2 Urea
0.5
caustic potash
0.1 EDTA-3Na
0.03 fragrance
0.2
ion exchange water
Remaining amount Production method An emulsion was obtained by a conventional method.
【0025】[0025]
【表1】[Table 1]
【0026】[0026]
【表2】[Table 2]
【0027】[0027]
【表3】[Table 3]
【0028】[0028]
【表4】[Table 4]
【0029】[0029]
【表5】[Table 5]
【0030】[0030]
【表6】[Table 6]
【0031】表1〜6の結果から明かなように、本発明
の化粧料は、肌のうるおい、肌のハリ、翌朝のうるおい
が従来品に比べ極めて優れていた。さらに、肌荒れ改善
効果にも優れていた。As is clear from the results in Tables 1 to 6, the cosmetics of the present invention were extremely superior to conventional products in terms of skin moisture, skin firmness, and next morning moisture. Furthermore, it was also excellent in improving skin roughness.
【0032】
実施例4 パック
重量% プロピレングリコール
2.0 ポリエチレン
グリコール4000
3.0 グリセリ
ン
15.0 エタノール
10.0 トラネキサム酸
のビタミンAエステル
10.0 ポリビニルアルコ
ール
10.0 オリ
ーブ油
3.0 乳酸
1.0
尿素
5.0 カルボキシメチルセル
ロース
0.07 メチルパラ
ベン
0.1 エチルパラベン
0.1 苛性カリ
0.
02 EDTA−3Na
0.01 香 料
0
.1 イオン交換水
残量 製 法
常法によりパックを得た。
本発明のパックは皮膚の新陳代謝を活発にし、皮膚の粘
弾力を増し、皮膚の保護と水分の保持性に優れ、適度な
うるおい、肌のハリを与えさらに、肌荒れ改善効果効果
にも優れていた。Example 4 Pack
Weight% propylene glycol
2.0 Polyethylene glycol 4000
3.0 Glycerin
15.0 Ethanol
10.0 Vitamin A ester of tranexamic acid
10.0 Polyvinyl alcohol
10.0 Olive oil
3.0 Lactic acid
1.0
urea
5.0 Carboxymethylcellulose
0.07 Methylparaben
0.1 Ethylparaben
0.1 caustic potash
0.
02 EDTA-3Na
0.01 fragrance
0
.. 1 Ion exchange water
Remaining amount Manufacturing method A pack was obtained by a conventional method. The pack of the present invention activates skin metabolism, increases skin elasticity, has excellent skin protection and moisture retention, provides appropriate moisture and skin firmness, and is also excellent in improving skin roughness. .
【0033】
実施例5 ヘアクリーム
重量% ミツロウ
3.0 ワセリ
ン
15.0 流動パラフィン
42.0 ポリオキシエチ
レン(5モル)
3.0
ステアリン酸エステル ポリオキシエチ
レン(6モル)
2.0
オレイルアルコールエーテル ポリオキ
シエチレン(6モル)
1.0
セチルアルコールエーテル トラ
ネキサム酸のビタミンCエステル
15.0 尿素
5.0 精製水
残余
香 料
適量 防腐剤
適量
製 法
常法によりヘアクリームを得た。Example 5 Hair cream
Weight% Beeswax
3.0 Vaseline
15.0 Liquid paraffin
42.0 Polyoxyethylene (5 mol)
3.0
Stearic acid ester polyoxyethylene (6 moles)
2.0
Oleyl alcohol ether polyoxyethylene (6 moles)
1.0
Cetyl alcohol ether Vitamin C ester of tranexamic acid
15.0 Urea
5.0 Purified water
remainder
fragrance
Appropriate amount preservative
Appropriate amount Manufacturing method A hair cream was obtained using a conventional method.
【0034】
実施例6 クリーム
重量% 1,3−ブチレングリコール
5.0 ポリエチレングリコール4
000
1.0 グリセリン
2.0
スクワラン
20.0 ワセリン
5.0
セトステアリルアルコール
3.0 ポリオキシエチレン(20モル)
1.5 オレイルアルコールエー
テル グリセリルモノステアレー卜
1.5 トラネキサム酸のナトリウム塩
0.1 尿素
0.5
乳酸ソータ゛
2.0 キサンタンガム(ケルトロー
ル商品名)
0.05 メチルパラベン
0.1 エチル
パラベン
0.2 EDTA−3Na
0.01 香 料
0.2 イオン交換水
残量 製 法
常法によりクリームを製造した。
本発明のクリームは皮膚の新陳代謝を活発にし、皮膚の
粘弾力を増し、皮膚の保護と水分の保持性に優れ、適度
なうるおい、肌のハリを与えさらに、肌荒れ改善効果効
果にも優れていた。Example 6 Cream
Weight% 1,3-butylene glycol
5.0 Polyethylene glycol 4
000
1.0 Glycerin
2.0
Squalane
20.0 Vaseline
5.0
Cetostearyl alcohol
3.0 Polyoxyethylene (20 mol)
1.5 Oleyl alcohol ether glyceryl monostearate
1.5 Sodium salt of tranexamic acid
0.1 Urea
0.5
Lactic acid sorter
2.0 Xanthan gum (Keltrol brand name)
0.05 Methylparaben
0.1 Ethylparaben
0.2 EDTA-3Na
0.01 fragrance
0.2 Ion exchange water
Remaining amount Production method A cream was produced using a conventional method. The cream of the present invention activates skin metabolism, increases skin viscosity and elasticity, has excellent skin protection and moisture retention, provides appropriate moisture and skin firmness, and is also excellent in improving skin roughness. .
【0035】
実施例7 乳 液
重量% グリセリン
2.0 スクワラ
ン
5.0 ワセリン
1.0 セトステアリルル
アルコール
0.3 ポリオキシエ
チレン(20モル)
1.5
オレイルアルコールエーテル グリセリールモノオレ
ート
1.5 トラネキサム酸
のカリウム塩
15.0 ポリアクリル
酸ナ卜リウム
0.03 エチ
ルパラベン
0.2 尿素
1.5 苛性カリ
0.1 EDTA−3Na
0.03 香 料
0.2
イオン交換水
残量 製 法
常法により乳液を得た。
本発明の乳液はいずれも皮膚の新陳代謝を活発にし、皮
膚の粘弾力を増し、皮膚の保護と水分の保持性に優れ、
適度なうるおい、肌のハリを与えさらに、肌荒れ改善効
果効果にも優れていた。Example 7 Emulsion
Weight% glycerin
2.0 Squalane
5.0 Vaseline
1.0 Cetostearyl alcohol
0.3 Polyoxyethylene (20 mol)
1.5
Oleyl alcohol ether glyceryl monooleate
1.5 Potassium salt of tranexamic acid
15.0 Sodium polyacrylate
0.03 Ethylparaben
0.2 Urea
1.5 Caustic potash
0.1 EDTA-3Na
0.03 fragrance
0.2
ion exchange water
Remaining amount Production method An emulsion was obtained by a conventional method. The emulsion of the present invention activates skin metabolism, increases skin elasticity, and has excellent skin protection and moisture retention.
It provided adequate moisture and firmness to the skin, and was also effective in improving rough skin.
Claims (1)
、もしくはその誘導体、またはこれらの混合物とを配合
することを特徴とする皮膚外用剤。1. An external skin preparation comprising urea and tranexamic acid, a salt thereof, a derivative thereof, or a mixture thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3142294A JP3001121B2 (en) | 1991-03-29 | 1991-03-29 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3142294A JP3001121B2 (en) | 1991-03-29 | 1991-03-29 | External preparation for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04305509A true JPH04305509A (en) | 1992-10-28 |
JP3001121B2 JP3001121B2 (en) | 2000-01-24 |
Family
ID=15312035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3142294A Expired - Fee Related JP3001121B2 (en) | 1991-03-29 | 1991-03-29 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3001121B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000256163A (en) * | 1999-03-05 | 2000-09-19 | Shiseido Co Ltd | Skin lotion |
JP2004002289A (en) * | 2002-03-25 | 2004-01-08 | Shiseido Co Ltd | Parakeratosis inhibitor |
JP2005170805A (en) * | 2003-12-08 | 2005-06-30 | Chanson Keshohin Kk | Skin care cosmetic, cosmetic set thereof and method for using them |
JP2021091643A (en) * | 2019-12-12 | 2021-06-17 | 株式会社ノエビア | Topical skin preparation |
-
1991
- 1991-03-29 JP JP3142294A patent/JP3001121B2/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000256163A (en) * | 1999-03-05 | 2000-09-19 | Shiseido Co Ltd | Skin lotion |
JP2004002289A (en) * | 2002-03-25 | 2004-01-08 | Shiseido Co Ltd | Parakeratosis inhibitor |
JP2005170805A (en) * | 2003-12-08 | 2005-06-30 | Chanson Keshohin Kk | Skin care cosmetic, cosmetic set thereof and method for using them |
JP2021091643A (en) * | 2019-12-12 | 2021-06-17 | 株式会社ノエビア | Topical skin preparation |
Also Published As
Publication number | Publication date |
---|---|
JP3001121B2 (en) | 2000-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4252899B2 (en) | Topically applied composition containing multivesicular emulsion and method for producing the same | |
CA2606140C (en) | External preparation for skin | |
AU2010224076B2 (en) | Thickening additive compositions | |
JPS6110504A (en) | Cosmetic composition | |
JPS59134706A (en) | Cosmetic | |
TWI766912B (en) | Aqueous formulation | |
WO2001019365A1 (en) | Pharmaceutical and/or cosmetical compositions | |
JPH0665049A (en) | External preparation for skin | |
JP2000355515A (en) | Cosmetic composition | |
JPH04305509A (en) | External preparation for skin | |
JPH05301812A (en) | Skin external preparation | |
JP2620770B2 (en) | External preparation for skin | |
JPH11302133A (en) | Cosmetic for scalp and hair | |
JPH03157311A (en) | Cosmetic for common acne | |
JPH07215832A (en) | Skin external preparation | |
US20220015992A1 (en) | Topical composition using a two-part form factor | |
JPS60116616A (en) | Cosmetic | |
JPH06145037A (en) | Skin external preparation | |
JPH01146815A (en) | External preparation for skin | |
JPH0456002B2 (en) | ||
JPH0788294B2 (en) | Cosmetics | |
JP2609884B2 (en) | Skin cosmetics | |
JPH0519526B2 (en) | ||
JPH11269023A (en) | Composition for external use | |
JPH05179129A (en) | Gel composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19991028 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071112 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081112 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081112 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091112 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101112 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |